Stocks News

LAST PRICE
108.7400
TODAY'S CHANGE (%)
Trending Up0.0800 (0.0736%)

Bid / Lots
108.6700/ 2
Ask / Lots
108.7300/ 2
Open / Previous Close
107.4500 / 108.6600
Day Range
Low 107.0500
High 109.1800
52 Week Range
Low 89.0000
High 212.4858
Volume
656,878
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- RBC Cuts Price Target on Illumina to $249 From $253, Maintains Outperform Rating, from 4 hours ago by MT Newswires
  4 hours ago by MT Newswires
  Companies Mentioned: ILMN
  07:30 AM EDT, 06/17/2024 (MT Newswires) -- Illumina (ILMN) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $100 to $253. (MT Newswires covers equity, commodity and economic research...
Jun 12, 2024
- Video: Illumina Employees Share Their "Why", from 9:45AM ET on Wednesday Jun 12, 2024 by Dow Jones
  9:45AM ET on Wednesday Jun 12, 2024 by Dow Jones
  Companies Mentioned: ILMN
  
  NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / What if the work you did every day could impact the lives of people you know? Or all of humanity? At Illumina, we believe that, together, we can use genomics to build a stronger world for the greater good. Regardless of background, department, or job function, a commitment to the mission connects our employees. Meet four professionals working at Illumina and learn what it means to them.
Jun 11, 2024
- Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations, from 9:15AM ET on Tuesday Jun 11, 2024 by Dow Jones
  9:15AM ET on Tuesday Jun 11, 2024 by Dow Jones
  Companies Mentioned: ILMN
  
  Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations
  
  PR Newswire
  
  SAN DIEGO, June 11, 2024
  
  Latest version includes a prebuilt pangenome capturing more genetic diversity, reducing ancestry bias, and improving accuracy
- DJ Illumina Is Maintained at Outperform by Evercore ISI Group, from 8:55AM ET on Tuesday Jun 11, 2024 by Dow Jones
  8:55AM ET on Tuesday Jun 11, 2024 by Dow Jones
  Companies Mentioned: ILMN
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ILMN/analyst-ratings
  
  (END) Dow Jones Newswires
  
  June 11, 2024 08:55 ET (12:55 GMT)
- Evercore ISI Cuts Price Target on Illumina to $175 From $195, from 8:24AM ET on Tuesday Jun 11, 2024 by MT Newswires
  8:24AM ET on Tuesday Jun 11, 2024 by MT Newswires
  Companies Mentioned: ILMN
  08:24 AM EDT, 06/11/2024 (MT Newswires) -- Illumina (ILMN) has an average rating of outperform and price targets ranging from $100 to $253, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from...

Jun 11, 2024
- Resmed Insider Sold Shares Worth $3,107,739, According to a Recent SEC Filing, from 3:12AM ET on Tuesday Jun 11, 2024 by MT Newswires
  3:12AM ET on Tuesday Jun 11, 2024 by MT Newswires
  Companies Mentioned: RMD
Jun 10, 2024
- PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia, from 9:05AM ET on Monday Jun 10, 2024 by GlobeNewswire
  9:05AM ET on Monday Jun 10, 2024 by GlobeNewswire
  Companies Mentioned: RMD
May 29, 2024
- Waters Insider Bought Shares Worth $332,900, According to a Recent SEC Filing, from 11:28AM ET on Wednesday May 29, 2024 by MT Newswires
  11:28AM ET on Wednesday May 29, 2024 by MT Newswires
  Companies Mentioned: WAT
May 23, 2024
- ResMed Says Research Shows Effectiveness of Positive Airway Pressure Therapy For Sleep Apnea, from 10:37AM ET on Thursday May 23, 2024 by MT Newswires
  10:37AM ET on Thursday May 23, 2024 by MT Newswires
  Companies Mentioned: RMD
- Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy, from 9:05AM ET on Thursday May 23, 2024 by GlobeNewswire
  9:05AM ET on Thursday May 23, 2024 by GlobeNewswire
  Companies Mentioned: RMD
May 22, 2024
- Deutsche Bank Adjusts Waters Price Target to $330 From $304, from 8:53AM ET on Wednesday May 22, 2024 by MT Newswires
  8:53AM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: WAT
May 16, 2024
- ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy, from 4:35PM ET on Thursday May 16, 2024 by GlobeNewswire
  4:35PM ET on Thursday May 16, 2024 by GlobeNewswire
  Companies Mentioned: RMD
- Waters Corp Insider Sold Shares Worth $1,446,560, According to a Recent SEC Filing, from 11:02AM ET on Thursday May 16, 2024 by MT Newswires
  11:02AM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: WAT
- MatrixCare Joins Health Gorilla's Qualified Health Information Network (QHIN) to Enhance Patient Data Access, from 8:05AM ET on Thursday May 16, 2024 by GlobeNewswire
  8:05AM ET on Thursday May 16, 2024 by GlobeNewswire
  Companies Mentioned: RMD
May 13, 2024
- Waters Corporation to Present at the Jefferies 2024 Healthcare Conference, from 2:00PM ET on Monday May 13, 2024 by PR Newswire
  2:00PM ET on Monday May 13, 2024 by PR Newswire
  Companies Mentioned: WAT

Illumina Inc
NASDAQ:ILMNUnited States

Search Criteria

Today

RBC Cuts Price Target on Illumina to $249 From $253, Maintains Outperform Rating, from 4 hours ago by MT Newswires

Jun 12, 2024

Video: Illumina Employees Share Their "Why", from 9:45AM ET on Wednesday Jun 12, 2024 by Dow Jones

Jun 11, 2024

Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations, from 9:15AM ET on Tuesday Jun 11, 2024 by Dow Jones

DJ Illumina Is Maintained at Outperform by Evercore ISI Group, from 8:55AM ET on Tuesday Jun 11, 2024 by Dow Jones

Evercore ISI Cuts Price Target on Illumina to $175 From $195, from 8:24AM ET on Tuesday Jun 11, 2024 by MT Newswires

Peers Headlines

Jun 11, 2024

Resmed Insider Sold Shares Worth $3,107,739, According to a Recent SEC Filing, from 3:12AM ET on Tuesday Jun 11, 2024 by MT Newswires

Jun 10, 2024

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia, from 9:05AM ET on Monday Jun 10, 2024 by GlobeNewswire

May 29, 2024

Waters Insider Bought Shares Worth $332,900, According to a Recent SEC Filing, from 11:28AM ET on Wednesday May 29, 2024 by MT Newswires

May 23, 2024

ResMed Says Research Shows Effectiveness of Positive Airway Pressure Therapy For Sleep Apnea, from 10:37AM ET on Thursday May 23, 2024 by MT Newswires

Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy, from 9:05AM ET on Thursday May 23, 2024 by GlobeNewswire

May 22, 2024

Deutsche Bank Adjusts Waters Price Target to $330 From $304, from 8:53AM ET on Wednesday May 22, 2024 by MT Newswires

May 16, 2024

ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy, from 4:35PM ET on Thursday May 16, 2024 by GlobeNewswire

Waters Corp Insider Sold Shares Worth $1,446,560, According to a Recent SEC Filing, from 11:02AM ET on Thursday May 16, 2024 by MT Newswires

MatrixCare Joins Health Gorilla's Qualified Health Information Network (QHIN) to Enhance Patient Data Access, from 8:05AM ET on Thursday May 16, 2024 by GlobeNewswire

May 13, 2024

Waters Corporation to Present at the Jefferies 2024 Healthcare Conference, from 2:00PM ET on Monday May 13, 2024 by PR Newswire